xanomeline

Xanomeline (LY-246708) is a functionally selective M1/M4 activator used in the study of neurological disorders such as schizophrenia and has shown promising treatment in preclinical trials. Xanomeline is well absorbed orally, crosses the blood-brain barrier and undergoes extensive liver metabolism with at least six metabolites.

Xanomeline oxalate (LY246708 oxalate), a potent and selective muscarinic receptor agonist (SMRA), effectively stimulates in vivo phosphoinositide hydrolysis. It is a valuable compound for Alzheimer's disease research.

Xanomeline tartrate (LY 246708 tartrate) is an M1 and M4 mAChR agonist with antipsychotic-like activity that improves cognition and can be used in studies of schizophrenia and Alzheimer's disease.

Xanomeline D3 is a deuterated compound of Xanomeline. Xanomeline (LY-246708) is a functionally selective M1/M4 activator used in the study of neurological disorders such as schizophrenia and has shown promising treatment in preclinical trials. Xanomeline is well absorbed orally, crosses the blood-brain barrier and undergoes extensive liver metabolism with at least six metabolites.

Xanomeline-[D6] Metabolite B (Standard) is a reference standard of Xanomeline-[D6] Metabolite B intended for quantitative analysis, quality control, and related biochemical research applications.

Xanomeline-[D6] Metabolite A (Standard) is a reference standard of Xanomeline-[D6] Metabolite A intended for quantitative analysis, quality control, and related biochemical research applications.